Meike Hutt

4PUBLICATIONS

38CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Jun 19, 2026

Author Correction: MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial.

|May 31, 2026

MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial.

|Aug 31, 2022

Quantitative immunopeptidomics reveals a tumor stroma-specific target for T cell therapy.

Gloria B Kim, Jens Fritsche, Sebastian Bunk

|Apr 20, 2017

Inhibition of HER3 activation and tumor growth with a human antibody binding to a conserved epitope formed by domain III and IV.

Lisa C Schmitt, Alexander Rau, Oliver Seifert

Pageof 1

Frequent Collaborators

Farastuk Bozorgmehr

Simon Laban

Manuel Ruh

Daniel Heudobler

Carsten Reinhardt

Stefan Knop

Heiko Becker

Moritz Kleemiss

Norbert Hilf

Dirk Jaeger

Frequent Collaborators

Farastuk Bozorgmehr

Simon Laban

Manuel Ruh

Daniel Heudobler